Hepatitis B Foundation

Hepatitis B Foundation, a tax-exempt nonprofit based in Doylestown, Pennsylvania, acts as a prime recipient of federal research grants focused on hepatitis B and hepatitis D virus research, clinical trial engagement, and public health capacity building. The foundation operates through two named subsidiaries — Bucks County Biotechnology Center, Inc., and Baruch S. Blumberg Institute — and competes in full-and-open federal grant competitions without set-aside posture.

The foundation's federal footprint concentrates almost entirely within the Department of Health and Human Services. The National Institute of Allergy and Infectious Diseases (NIAID) dominates the award count with 9 grants, including the 2026 International HBV Meeting (award date August 17, 2026, completion July 31, 2027), which provides travel and registration support for U.S.-based researchers and early-career scientists attending the annual International HBV Meeting — the sole international forum bringing together the global research community studying hepatitis B and hepatitis D virus infection, persistence, pathogenesis, and therapeutic development. The 2024 International HBV Meeting (awarded August 6, 2024, completing July 31, 2025) and 2023 International HBV Meeting (awarded July 12, 2023, completing June 30, 2024) followed the same model, rotating meeting locations to Japan, Chicago, Europe, and Singapore to support early-career and underrepresented researchers. The Centers for Disease Control and Prevention holds 5 awards across recent activity. A cooperative agreement with the Office of the Commissioner of the Food and Drug Administration (awarded May 10, 2023, completing April 30, 2025) addresses health disparities by examining how ethnic minorities and people living with hepatitis B experienced COVID-19, vaccine uptake decisions, and access to clinical trials — using mixed-methods research with interviews, surveys, and a community advisory board. A congressionally directed project grant through the Healthcare Systems Bureau (awarded August 1, 2022, completing July 31, 2024) funded a Pennsylvania viral hepatitis elimination initiative building public health infrastructure and partnerships through ECHO tele-mentoring, training for community-based organizations serving Asian American and African immigrant populations, and systems-level integration of hepatitis B screening and vaccination.

The foundation holds subrecipient positions on four federal grants: a University of Pennsylvania NIAID-funded study (sub-award June 17, 2026) where the foundation contributes expertise in data collection instrument development and manages an HIV/HBV community advisory board with recruitment through its 12,000-subscriber newsletter and 70,000 social-media followers; a Johns Hopkins University Long-Acting/Extended Release Antiretroviral Resource Program (LEAP) sub-award (March 6, 2025); and two sub-awards under the Association of Asian/Pacific Community Health Organizations (March 21, 2025, and September 29, 2025) establishing collaborative partnerships to advance shared public health interests. Recent award volume has grown modestly — one award in 2023, one in 2024, three in 2025, and two in 2026 — with combined potential value of $63 thousand across all 28 recent awards. Two awards reach ultimate completion within the next twenty-four months.